MYLK and inflammatory bowel disease: Altered trans-cellular and para-cellular permeability have been described in IBD, evidenced by the presence of intracellular bacteria inside epithelial cells, and by modified tight junction protein expression and increased myosin light chain kinase (MLCK) activity (Yu Chia-Hui, 2018).